Top Markets
#1 MowCat MowCat +49.11%
#2 Bermuda Shorts Bermuda Shorts +28.81%
#3 Velvet Velvet +25.14%
#4 Biconomy Biconomy +24.73%
#5 Quack AI Quack AI +19.77%
#6 Derive Derive +17.09%
#7 Zerebro Zerebro +13.86%
#8 Perle Perle +13.64%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.27%
#10 Playnance Playnance +12.59%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Braster S.A. Braster S.A.

Braster S.A.

BRA
Rangering i aksjer #34866
Braster S.A. globally manufactures and distributes innovative diagnostic... Braster S.A. globally manufactures and distributes innovative diagnostic devices for at-home breast screening. Its product line includes the Braster System, designed for individual at-home breast examinations, and the Braster Pro, tailored for clinical application by healthcare professionals. Initially operating as BRASTER spólka z ograniczona odpowiedzialnoscia, the firm formally changed its designation to Braster S.A. in December 2012. Established in 2008, Braster S.A. is headquartered in Ozarów Mazowiecki, Poland.
Aksjekurs
$0.16328231
Sist synkronisert: 2024-07-12
Markedsverdi
$4.80M
Endring (1 dag)
17.36%
Endring (1 år)
0.00%
Land
PL
Handel Braster S.A. (BRA)

Kategori

Healthcare
Utbytteavkastning for Braster S.A. (BRA)
Braster S.A. (aksjesymbol: BRA) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Braster S.A. (BRA) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US